SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
14.98
+1.71 (12.89%)
At close: Jul 2, 2026, 4:00 PM EDT
14.95
-0.04 (-0.23%)
After-hours: Jul 2, 2026, 5:10 PM EDT
SLS Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
2.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.00M | -6.60M | -86.84% |
| Dec 31, 2021 | 7.60M | 5.70M | 300.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSLS News
- 1 day ago - Sellas Life Sciences falls -11.0% - TheFly
- 2 days ago - Sellas Life Sciences falls -8.9% - TheFly
- 3 days ago - Sellas Life Sciences rises 16.8% - TheFly
- 6 days ago - What's driving SLS stock higher today and what comes next? - Invezz
- 16 days ago - SELLAS Life Sciences Group Transcript: AGM 2026 - Transcripts
- 5 weeks ago - SELLAS Life Sciences Group Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 6 weeks ago - SELLAS Life Sciences Group Transcript: A.G.P.'s Annual Virtual Healthcare Conference - Transcripts
- 6 weeks ago - SELLAS Life Sciences Group Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts